With detailed knowledge of both technical and commercial aspects of biotech/biopharma, Shawn has extensive relationships with some of the leading Life Sciences companies. He's been involved in biological drug markets from the beginning of mAB therapy. His ability to mix scientific fundamentals with business acumen makes him a unique resource when moving from lab to market.
After early career stops as an analytical chemist at Hundtingdon Analytical Services and research scientist for Bristol-Myers Squibb, Shawn spent over a decade moving through Invitrogen Corporation's GIBCO Cell Culture division. First as a research and development scientist, he gradually assumed increasing levels of managerial responsibility in manufacturing operations, sales and marketing and ultimately business development efforts in the company's BioProduction business unit.
Shawn earned a Bachelors of Science degree in Biochemical Pharmacology from the University at Buffalo and enhanced his education through numerous advanced certificate/executive courses from accredited institutions throughout the U.S.